The abstract is read at the publisher; the summary is JClub's.
The small intestine microbiome is positioned as a distinct, understudied source of microbial therapeutics, with its host–diet interactions offering opportunities beyond fecal-focused research.
- Why it matters: Most gut microbiome work has relied on fecal communities, leaving the small intestine’s distinct environment and host interactions insufficiently characterized for therapeutic development.
- What they did: This Review synthesizes current knowledge on small intestine microbial composition and host physiology links, and outlines how next-generation microbial therapeutics could be derived from small intestinal communities.
- The result: Small intestinal microorganisms are anticipated to enable novel microbial therapeutics relevant to improving small intestinal diseases and broader systemic human health.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.